Showing results (81-90 of 144) with videos related to
Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|September 1, 1987
Effect of high-dose etodolac on renal functionD C Brater, D Brown-Cartwright, S A Anderson, et al.Journal of Hypertension|February 1, 1984
Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensivesD C Brater, S Anderson, N M Kaplan, et al.The Journal of Urology|June 1, 1985
Lack of effect of prostaglandin inhibition on calcium excretion in normal volunteersV K Rocco, K Sakhaee, C Y Pak, et al.Pharmacoeconomics|September 8, 2000
Healthcare costs of patients with heart failure treated with torasemide or furosemideK T Stroupe, M M Forthofer, D C Brater, et al.Clinical Pharmacology and Therapeutics|April 1, 1993
Lack of presystemic inversion of (R)- to (S)-ibuprofen in humansS D Hall, A C Rudy, P M Knight, et al.Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1979
Attenuation of furosemide's diuretic effect by indomethacin: pharmacokinetic evaluationD E Smith, D C Brater, E T Lin, et al.Clinical Science (London, England : 1979)|October 1, 1984
Dependence of urinary prostaglandin E2 excretion on urinary volume rather than solute handling or segmental nephron function in manS Kaojarern, P Chennavasin, A Burdette, et al.Journal of the American Society of Nephrology : JASN|July 1, 1996
Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failureD L Vargo, D C Brater, D W Rudy, et al.Clinical Pharmacology and Therapeutics|October 1, 1982
Clinical comparison of cimetidine and ranitidineD C Brater, M N Peters, F N Eshelman, et al.Clinical Pharmacology and Therapeutics|November 1, 1977
Kinetics of oral ethambutol in the normal subjectC S Lee, J G Gambertoglio, D C Brater, et al.Pageof 15